Your browser doesn't support javascript.
loading
Physiologic changes in the hepatopulmonary syndrome before and after liver transplant: A longitudinal and predictor analysis.
Zhao, Xun; Kotha, Sreelakshmi; Nayyar, Dhruv; Ma, Xiayi; Lilly, Leslie; Castel, Hélène; Gupta, Samir.
Affiliation
  • Zhao X; Department of Gastroenterology and Hepatology, McGill University, Montreal, Canada.
  • Kotha S; Department of Multi-Organ Transplant, Toronto General Hospital, University of Toronto, Toronto, Canada.
  • Nayyar D; Department of Hepatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Ma X; Department of Medicine, University of Toronto, Toronto, Canada.
  • Lilly L; Li Ka Shing Knowledge Institute of St. Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, Canada.
  • Castel H; Department of Multi-Organ Transplant, Toronto General Hospital, University of Toronto, Toronto, Canada.
  • Gupta S; Department of Hepatology and Liver Transplantation, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Canada.
Hepatology ; 79(3): 636-649, 2024 Mar 01.
Article in En | MEDLINE | ID: mdl-37732952
ABSTRACT
BACKGROUND AND

AIMS:

Hepatopulmonary syndrome (HPS) is a common complication of liver disease defined by abnormal oxygenation and intrapulmonary vascular dilatation, treated with liver transplantation. Little is known about changes in HPS physiological parameters over time. We sought to describe baseline clinical and physiological characteristics in HPS and their relationships, temporal changes in physiological parameters before and after transplant, and predictors of changes in oxygenation. APPROACH AND

RESULTS:

This was a retrospective cohort study in the Canadian HPS Program (n = 132). Rates of change after diagnosis were -3.7 (-6.4, -0.96) mm Hg/year for partial pressure of arterial oxygen (PaO 2 ); -26 (-96, 44) m/year for 6-minute walk distance, and 3.3% (-6.6, -0.011) predicted/year for diffusion capacity. Noninvasive shunt of ≥ 20% predicted a slower PaO 2 decline by 0.88 (0.36, 1.4) mm Hg/month. We identified 2 PaO 2 deterioration classes-"very severe disease, slow decliners" (PaO 2 45.0 mm Hg; -1.0 mm Hg/year); and "moderate disease, steady decliners" (PaO 2 65.5 mm Hg; -2.5 mm Hg/year). PaO 2 increased by 6.5 (5.3, 7.7) mm Hg/month in the first year after transplant. The median time to normalization was 149 (116, 184) days. Posttransplant improvement in PaO 2 was 2.5 (0.1, 4.9) mm Hg/month faster for every 10 mm Hg greater pretransplant orthodeoxia.

CONCLUSIONS:

We present a large and long longitudinal data analysis in HPS. In addition to rates of physiological decline and improvement before and after liver transplantation, we present novel predictors of PaO 2 decline and improvement rates. Our findings enhance our understanding of the natural history of HPS and provide pathophysiologic clues. Importantly, they may assist providers in prognostication and prioritization before and after transplant.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Liver Transplantation / Hepatopulmonary Syndrome Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Hepatology Year: 2024 Document type: Article Affiliation country: Canadá

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Liver Transplantation / Hepatopulmonary Syndrome Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Hepatology Year: 2024 Document type: Article Affiliation country: Canadá